A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese Participants
Clinical trial NCT06243198 · COMPLETED
Trial details
- NCT number
- NCT06243198
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-28
- Primary completion
- 2024-09-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.